These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19118029)

  • 1. S100A2 induces metastasis in non-small cell lung cancer.
    Bulk E; Sargin B; Krug U; Hascher A; Jun Y; Knop M; Kerkhoff C; Gerke V; Liersch R; Mesters RM; Hotfilder M; Marra A; Koschmieder S; Dugas M; Berdel WE; Serve H; Müller-Tidow C
    Clin Cancer Res; 2009 Jan; 15(1):22-9. PubMed ID: 19118029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer.
    Diederichs S; Bulk E; Steffen B; Ji P; Tickenbrock L; Lang K; Zänker KS; Metzger R; Schneider PM; Gerke V; Thomas M; Berdel WE; Serve H; Müller-Tidow C
    Cancer Res; 2004 Aug; 64(16):5564-9. PubMed ID: 15313892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
    Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
    Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in mice.
    Bulk E; Hascher A; Liersch R; Mesters RM; Diederichs S; Sargin B; Gerke V; Hotfilder M; Vormoor J; Berdel WE; Serve H; Müller-Tidow C
    Cancer Res; 2008 Mar; 68(6):1896-904. PubMed ID: 18339871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.
    Feng G; Xu X; Youssef EM; Lotan R
    Cancer Res; 2001 Nov; 61(21):7999-8004. PubMed ID: 11691825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
    Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
    Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma.
    Tsai WC; Tsai ST; Jin YT; Wu LW
    Mol Cancer Res; 2006 Aug; 4(8):539-47. PubMed ID: 16908593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
    Kim SH; Choi HY; Lee J; Son DS; Lee HS; Song IS; Lim YS; Hong YS; Kim J; Choi YS
    J Surg Oncol; 2007 Mar; 95(4):337-46. PubMed ID: 17326127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
    Zech VF; Dlaska M; Tzankov A; Hilbe W
    Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer.
    Strazisar M; Rott T; Glavac D
    Lung Cancer; 2009 Mar; 63(3):354-9. PubMed ID: 18656279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
    Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
    Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer.
    Ito S; Kawano Y; Katakura H; Takenaka K; Adachi M; Sasaki M; Shimizu K; Ikenaka K; Wada H; Tanaka F
    Lung Cancer; 2006 Jan; 51(1):79-88. PubMed ID: 16225959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice.
    Ogino H; Yano S; Kakiuchi S; Muguruma H; Ikuta K; Hanibuchi M; Uehara H; Tsuchida K; Sugino H; Sone S
    Clin Cancer Res; 2008 Feb; 14(3):660-7. PubMed ID: 18245525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy.
    Bartling B; Rehbein G; Schmitt WD; Hofmann HS; Silber RE; Simm A
    Eur J Cancer; 2007 Sep; 43(13):1935-43. PubMed ID: 17689067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis.
    Shintani Y; Higashiyama S; Ohta M; Hirabayashi H; Yamamoto S; Yoshimasu T; Matsuda H; Matsuura N
    Cancer Res; 2004 Jun; 64(12):4190-6. PubMed ID: 15205330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of S100A2 as a target of the DeltaNp63 oncogenic pathway.
    Hibi K; Fujitake S; Takase T; Kodera Y; Ito K; Akiyama S; Shirane M; Nakao A
    Clin Cancer Res; 2003 Sep; 9(11):4282-5. PubMed ID: 14519656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target.
    Fan T; Li R; Todd NW; Qiu Q; Fang HB; Wang H; Shen J; Zhao RY; Caraway NP; Katz RL; Stass SA; Jiang F
    Cancer Res; 2007 Aug; 67(16):7901-6. PubMed ID: 17699796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated antigen L6 and the invasion of human lung cancer cells.
    Kao YR; Shih JY; Wen WC; Ko YP; Chen BM; Chan YL; Chu YW; Yang PC; Wu CW; Roffler SR
    Clin Cancer Res; 2003 Jul; 9(7):2807-16. PubMed ID: 12855661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.